Wird geladen...
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
BACKGROUND: Triple-negative breast cancer has extremely high risk of relapse due to the lack of targeted therapies, intra- and inter-tumoral heterogeneity, and the inherent and acquired resistance to therapies. In this study, we evaluate the potential of prostate-specific membrane antigen (PSMA) as...
Gespeichert in:
| Veröffentlicht in: | Breast Cancer Res |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6805467/ https://ncbi.nlm.nih.gov/pubmed/31640747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-019-1205-1 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|